CHPA Statement on FDA Commissioner Marty Makary’s Resignation

(WASHINGTON, D.C.) - The Consumer Healthcare Products Association (CHPA) today issued the following statement regarding the resignation of U.S. Food and Drug Administration (FDA) Commissioner Dr. Marty Makary:

"CHPA appreciates Dr. Makary's public service at the FDA during a consequential time for healthcare," said CHPA President & CEO Scott Melville. "Throughout his tenure, Commissioner Makary consistently recognized and publicly emphasized the important role self-care products play in expanding access, lowering costs, and helping Americans more easily manage their health.

"The unprecedented pace of leadership transition across the FDA this past year underscores the need for regulatory stability, predictability, and continuity. It's essential to protect public health, maintain consumer confidence, and enable industry innovation.

"CHPA looks forward to continuing to work collaboratively with Acting Commissioner Diamantas and the broader FDA leadership team to help translate access and affordability priorities into policies and actions that expand Americans' ability to obtain safe, effective, and reliable self-care products."

The Consumer Healthcare Products Association (CHPA) Educational Foundation is a 501 (c)(3) nonprofit organization that empowers consumers to make smart self-care decisions by providing information and guidance on how to safely use, store, and dispose of OTC medicines and dietary supplements. Its mission is to serve as the trusted source of information on the responsible use of consumer healthcare products. Visit chpa.org/Foundation or HealthInHand.org for more information.